Provider organizations currently have little influence over the strategy of pharmaceutical companies or how these and other life sciences companies develop treatments for their patients. At the same time, pharmaceutical companies have limited access to the wealth of data and clinical information that provider organizations are accumulating in their EHRs.

It may seem daunting or even counterintuitive to envision a formal collaboration between provider and pharma when it comes to either’s clinical strategy. But that was in the old age of healthcare.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access